| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Department of Breast Surgery and Endocrine Research Laboratory, Roswell Park Memorial Institute, Buffalo, New York 14203
Increased release of pituitary prolactin as a result of placement of electrolytic lesions in the median eminence of the hypothalamus greatly accelerated the growth rate of carcinogen-induced mammary tumors in rats. Ovariectomy in these rats induced a rapid regression of tumors in spite of high plasma levels of prolactin. Grafting a pair of ovaries into ovariectomized rats with lesions of the median eminence did not alter the levels of plasma prolactin, but it did cause a rapid resumption of tumor growth. It is concluded that the prolactin stimulus to growth of mammary tumor is dependent on the presence of ovarian hormones.
Received 10/ 3/72. Accepted 11/ 9/72.
This article has been cited by other articles:
![]() |
P. M. Schyve, F. Smithline, and H. Y. Meltzer Neuroleptic-induced Prolactin Level Elevation and Breast Cancer: An Emerging Clinical Issue Arch Gen Psychiatry, November 1, 1978; 35(11): 1291 - 1301. [Abstract] [PDF] |
||||
![]() |
D. T. KIANG and BJ. KENNEDY Tamoxifen (Antiestrogen) Therapy in Advanced Breast Cancer Ann Intern Med, December 1, 1977; 87(6): 687 - 690. [Abstract] [PDF] |
||||
![]() |
E. Johnson, J. Seely, W. White, and E. DeSombre Endocrine-dependent rat mammary tumor regression: use of a gonadotropin releasing hormone analog Science, October 15, 1976; 194(4262): 329 - 330. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |